PH22998A - Ergot peptide alkaloids, pharmaceutical compositions containing them and theit method of use - Google Patents

Ergot peptide alkaloids, pharmaceutical compositions containing them and theit method of use

Info

Publication number
PH22998A
PH22998A PH27690A PH27690A PH22998A PH 22998 A PH22998 A PH 22998A PH 27690 A PH27690 A PH 27690A PH 27690 A PH27690 A PH 27690A PH 22998 A PH22998 A PH 22998A
Authority
PH
Philippines
Prior art keywords
theit
pharmaceutical compositions
compositions containing
peptide alkaloids
ergot peptide
Prior art date
Application number
PH27690A
Other languages
English (en)
Inventor
Hans Kobel
Jean-Jacques Sanglier
Hans Tscherter
Georg Bolliger
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH22998A publication Critical patent/PH22998A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
PH27690A 1981-08-07 1982-08-06 Ergot peptide alkaloids, pharmaceutical compositions containing them and theit method of use PH22998A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5104/81A CH649300A5 (de) 1981-08-07 1981-08-07 Ergopeptinderivate, ihre herstellung und verwendung.

Publications (1)

Publication Number Publication Date
PH22998A true PH22998A (en) 1989-02-24

Family

ID=4287999

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27690A PH22998A (en) 1981-08-07 1982-08-06 Ergot peptide alkaloids, pharmaceutical compositions containing them and theit method of use

Country Status (27)

Country Link
US (3) US4542135A (sv)
JP (1) JPS5843982A (sv)
AT (1) AT382156B (sv)
AU (1) AU558414B2 (sv)
BE (1) BE894046A (sv)
CA (1) CA1191802A (sv)
CH (1) CH649300A5 (sv)
CS (1) CS235303B2 (sv)
DD (2) DD211582A5 (sv)
DE (1) DE3228230A1 (sv)
DK (1) DK352082A (sv)
ES (2) ES8402348A1 (sv)
FI (1) FI72979C (sv)
FR (1) FR2511003B1 (sv)
GB (1) GB2109795B (sv)
GR (1) GR77262B (sv)
HU (2) HU190405B (sv)
IE (1) IE53647B1 (sv)
IL (1) IL66471A (sv)
IT (1) IT1152489B (sv)
MY (1) MY8600311A (sv)
NL (1) NL8203067A (sv)
NZ (1) NZ201504A (sv)
PH (1) PH22998A (sv)
PT (1) PT75384B (sv)
SE (1) SE452011B (sv)
ZA (1) ZA825727B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
JPS60104129A (ja) * 1983-11-11 1985-06-08 Hitachi Ltd フッ素含有ポリアミド酸誘導体及びポリイミドの製造方法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
HU193317B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing 2-bromo-alpha-ergochristin
TW252979B (sv) * 1992-12-24 1995-08-01 Erba Carlo Spa
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
US20070022720A1 (en) * 2005-07-27 2007-02-01 The Toro Company Cleaner for cooling system screen of outdoor power equipment unit
EP2515654A4 (en) * 2009-12-23 2013-04-24 Map Pharmaceuticals Inc NEW ERGOLINANALOGA
MX2013015373A (es) 2011-06-23 2014-02-11 Map Pharmaceuticals Inc Nuevos analogos de fluoroergolina.
SG11201403434YA (en) 2011-12-19 2014-09-26 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
SG10201506202RA (en) 2011-12-21 2015-09-29 Map Pharmaceuticals Inc Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
CZ304709B6 (cs) * 2013-07-25 2014-09-03 Teva Czech Industries S.R.O. Izolovaný kmen houby Claviceps purpurea (Fr.) Tul., CCM 8404
CN113308442B (zh) * 2021-04-28 2023-06-27 天津大学 重组酿酒酵母菌株及其构建方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314959A (en) * 1961-05-10 1967-04-18 Sandoz Ltd Intermediates for the synthesis of ergot alkaloids
FR2292M (fr) * 1962-06-27 1964-01-27 Sandoz Sa Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.
CH602765A5 (sv) * 1974-09-27 1978-07-31 Sandoz Ag
CH602766A5 (en) * 1974-09-27 1978-07-31 Sandoz Ag 10-Alpha-methoxy-di:hydro-beta-ergosine derivs.
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
CH626373A5 (sv) * 1977-02-22 1981-11-13 Sandoz Ag
GB1584464A (en) * 1977-04-19 1981-02-11 Farmaceutici Italia Ergot alkaloids
DE2717953A1 (de) * 1977-04-22 1978-10-26 Sandoz Ag Neue therapeutische mischung und verfahren zu deren herstellung
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
CH636011A5 (en) * 1978-01-01 1983-05-13 Sandoz Ag Administration forms for organic compounds
DE2962303D1 (en) * 1978-01-20 1982-04-29 Sandoz Ag Derivatives of ergopeptide alkaloids, process for their preparation and pharmaceutical compositions containing them
DE2803543A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Ergopeptidalkaloidderivate, ihre verwendung und herstellung
YU40046B (en) * 1978-09-04 1985-06-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-9,10-dihydroergosine
US4609731A (en) * 1979-10-10 1986-09-02 Sandoz Ltd. Process for brominating ergot alkaloids
DD200571A1 (de) * 1981-07-22 1983-05-18 Alfred Baumert Verfahren zur herstellung von ergopeptinen mit modifiziertem prolinteil
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.

Also Published As

Publication number Publication date
IL66471A (en) 1986-02-28
DK352082A (da) 1983-02-08
CH649300A5 (de) 1985-05-15
CS235303B2 (en) 1985-05-15
NZ201504A (en) 1986-08-08
SE452011B (sv) 1987-11-09
US4681880A (en) 1987-07-21
AU8678582A (en) 1983-03-03
IL66471A0 (en) 1982-12-31
ATA302682A (de) 1986-06-15
JPH0437836B2 (sv) 1992-06-22
ZA825727B (en) 1984-03-28
PT75384B (en) 1985-06-28
DD206379A5 (de) 1984-01-25
FI72979C (sv) 1987-08-10
FI822670A0 (fi) 1982-07-30
ES526119A0 (es) 1985-04-16
BE894046A (fr) 1983-02-07
MY8600311A (en) 1986-12-31
AT382156B (de) 1987-01-26
SE8204585L (sv) 1983-02-08
IE821906L (en) 1983-02-07
IT8222768A0 (it) 1982-08-06
FI822670L (fi) 1983-02-08
IE53647B1 (en) 1989-01-04
HU190405B (en) 1986-09-29
US4542135A (en) 1985-09-17
DD211582A5 (de) 1984-07-18
ES8504825A1 (es) 1985-04-16
HU193373B (en) 1987-09-28
DE3228230A1 (de) 1983-02-17
ES514766A0 (es) 1984-01-16
US4804660A (en) 1989-02-14
GR77262B (sv) 1984-09-11
NL8203067A (nl) 1983-03-01
IT1152489B (it) 1986-12-31
FI72979B (fi) 1987-04-30
HUT37960A (en) 1986-03-28
GB2109795B (en) 1985-07-03
AU558414B2 (en) 1987-01-29
GB2109795A (en) 1983-06-08
FR2511003B1 (fr) 1986-12-05
FR2511003A1 (fr) 1983-02-11
ES8402348A1 (es) 1984-01-16
SE8204585D0 (sv) 1982-08-05
JPS5843982A (ja) 1983-03-14
CA1191802A (en) 1985-08-13
PT75384A (en) 1982-09-01

Similar Documents

Publication Publication Date Title
PH22764A (en) New bicyclic compounds, method of use and pharmaceutical formulations containing such compounds
PH22998A (en) Ergot peptide alkaloids, pharmaceutical compositions containing them and theit method of use
PH20243A (en) Cephalosporin derivatives, pharmaceutical formulation containing same and method of use thereof
PH23357A (en) Cyclosporin compound,pharmaceutical composition containing said compound and method of use thereof
PH19645A (en) New derivatives of bicyclic amino acids and pharmaceutical composition containing them
PH18979A (en) Banzazepine derivatives,their pharmaceutical compositions and method of use
DE3264121D1 (en) Ergoline derivatives, processes for their preparation and pharmaceutical compositions containing them
IL66113A0 (en) Pharmaceutical formulations containing ergot alkaloids
PH23447A (en) B-actam compounds,pharmaceutical compositions containing the same and method of use thereof
PH19352A (en) Fluoromethylthiooxacephalosporins derivatives compositions containing same and method of use thereof
DE3666922D1 (en) Method and device for the recovery of powder
PH23384A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof
PH20358A (en) Mitomycin analogs pharmaceutical composition containing same and method of use thereof
PT75042B (en) Process for the preparation of apovincaminates and pharmaceutical compositions containing them
PT83305A (en) Process for the preparation of xanthine derivatives and pharmaceutical compositions containing them
PT82072A (en) Process for the preparation of pyrazolopyridine derivatives and of pharmaceutical compositions containing the same
PH20385A (en) Ergot alkaloids, compositions containing the same and method of use thereof
DE3272695D1 (en) Gelatinized highly explosive composition and method of preparation
PH19347A (en) Triazole derivatives,pharmaceutical composition containing same and method of use thereof
PT81759A (en) Process for the preparation of 8-alpha-acylamino ergolines and of pharmaceutical compositions containing them
PH17494A (en) New ergoline derivatives and pharmaceutical compositions thereof
DE3266377D1 (en) Preparation and use of a quinoline derivative, and composition containing it
EP0058079A3 (en) Imidazole derivative, method of preparation thereof, and pharmaceutical composition containing same
PH18155A (en) Ergot peptide alkaloid derivatives and pharmaceutical compositions containing them
PH24277A (en) New derivatives of bicyclic amino acids,pharmaceutical compositions containing them and method of use thereof